Metraipolis › archive › dc_6e28bd99de24

Secondary risks of bleeding and associated outcome after tirofiban application during interventional treatment of intracranial aneurysms — Europe PMC PMID:42382654

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42382654
DOI
10.1016/j.bas.2026.106125
License (as archived)
solo-consultazione
Archived
2026-10-31T14:19:41.087Z
SHA-256 of the archived text
46c0aaf81b458879bfef32099b6371ff4c63d699ef72f8111e8af7836e6aabe5
Stable URL of this page
https://metraipolis.com/documento/dc_6e28bd99de24

How to cite

Secondary risks of bleeding and associated outcome after tirofiban application during interventional treatment of intracranial aneurysms — Europe PMC PMID:42382654 — Europe PMC (en), https://europepmc.org/article/MED/42382654 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e28bd99de24 (Metraipolis archive dc_6e28bd99de24, sha256 46c0aaf81b458879bfef32099b6371ff4c63d699ef72f8111e8af7836e6aabe5)
BibTeX
@misc{dc6e28bd99de24,
  title = {Secondary risks of bleeding and associated outcome after tirofiban application during interventional treatment of intracranial aneurysms — Europe PMC PMID:42382654},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382654},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e28bd99de24; sha256 46c0aaf81b458879bfef32099b6371ff4c63d699ef72f8111e8af7836e6aabe5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382654. Agents can read the archived copy with the MCP tool read_document.